Emergent BioSolutions (EBS) Debt Ratio (2010 - 2026)

Emergent BioSolutions' Debt Ratio history runs 17 years deep, the most recent figure standing at 0.43 for Q1 2026.

• On a quarterly basis, Debt Ratio fell 6.94% year-over-year to 0.43 in Q1 2026; TTM through Mar 2026 was 0.43, a 6.94% decrease from a year earlier, with the FY2025 full-year figure at 0.43, down 9.15% from the prior year.
• Debt Ratio steadied at 0.43 in Q1 2026 per EBS's latest filing, from 0.43 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.57 in Q2 2024 and bottomed at 0.14 in Q4 2022.
• The 5-year median for Debt Ratio is 0.43 (2025), against an average of 0.38.
• Across the five-year window, Debt Ratio sank 50.69% in 2022 and jumped 232.14% in 2024, its largest moves.
• Year by year, Debt Ratio stood at 0.14 in 2022, then soared by 72.89% to 0.24 in 2023, then surged by 95.01% to 0.48 in 2024, then slipped by 9.15% to 0.43 in 2025, then gained by 0.13% to 0.43 in 2026.
• Per Business Quant, the three latest EBS Debt Ratio figures stand at 0.43 (Q1 2026), 0.43 (Q4 2025), and 0.47 (Q3 2025).